FDA Approval Summary: Alpelisib plus fulvestrant for patients with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 09 November 2020 |
| Author/s |
author: Laura L Fernandes Kirsten B Goldberg Emily Li Tatiana Prowell Jennifer J Gao |
| Publication date | November 9, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |